Cargando…

Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study

BACKGROUND: Immune checkpoint inhibitors (ICI) are anti-cancer drugs that act by enhancing anti-tumour immunity. Due to their mechanism of action, they have been associated with immune related adverse events (Ir-AE), including musculoskeletal manifestations. AIM: To assess a) the prevalence, clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daoussis, Dimitrios, Melissaropoulos, Konstantinos, Dimitroulas, Theodoros, Andreadis, Haralambos, Christopoulou, Athina, Douganiotis, George, Makatsoris, Thomas, Koutras, Angelos, Georgiou, Panagiotis, Kalofonos, Haralabos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2020
Materias:	Research Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362123/ https://www.ncbi.nlm.nih.gov/pubmed/32676566 http://dx.doi.org/10.31138/mjr.31.2.239

Ejemplares similares

Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2020)

RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
por: Sirinian, Chaido, et al.
Publicado: (2021)

Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients
por: Kottorou, Anastasia, et al.
Publicado: (2023)

NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development
por: Antonacopoulou, Anna, et al.
Publicado: (2020)

PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors
por: Dimitrakopoulos, Foteinos-Ioannis, et al.
Publicado: (2020)

The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration Differently
por: Lymperatou, Dionysia, et al.
Publicado: (2013)

Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2021)

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study
por: Dimitrakopoulos, Foteinos-Ioannis, et al.
Publicado: (2022)

Identification of a seasonal pattern to brain metastases
por: Sakellakis, Minas, et al.
Publicado: (2016)

Quiescent Systemic Lupus Erythematosus Manifesting with Thrombotic Thrombocytopenic Purpura and Acute Renal Failure: A Case Report and Short Literature Review
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2021)

Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2019)

Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness
por: Sirinian, Chaido, et al.
Publicado: (2022)

Adhesion strength and anti-tumor agents regulate vinculin of breast cancer cells
por: Metsiou, Despoina Nektaria, et al.
Publicado: (2022)

Differentially Methylated Ultra-Conserved Regions Uc160 and Uc283 in Adenomas and Adenocarcinomas Are Associated with Overall Survival of Colorectal Cancer Patients
por: Kottorou, Anastasia E., et al.
Publicado: (2020)

Ulcerative colitis six years after colon cancer: only a coincidence?
por: Sakellakis, Minas, et al.
Publicado: (2014)

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Klavdianou, Kalliopi, et al.
Publicado: (2021)

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
por: Argyriou, Andreas A, et al.
Publicado: (2014)

NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2018)

Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2019)

Antiproliferative effect of exemestane in lung cancer cells
por: Koutras, Angelos, et al.
Publicado: (2009)

Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2022)

Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients
por: Bourika, Klio, et al.
Publicado: (2019)

Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem
por: Dimitrakopoulos, Fotinos-Ioannis D., et al.
Publicado: (2015)

Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas
por: Kottorou, Anastasia E., et al.
Publicado: (2018)

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment
por: Fragoulis, George E, et al.
Publicado: (2019)

How Should Concurrent Arterial and Venous Thrombosis Associated With SARS-CoV-2 Infection Be Managed?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2020)

Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
por: Daoussis, Dimitrios, et al.
Publicado: (2019)

Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence
por: Dimosiari, Athina, et al.
Publicado: (2023)

Peripheral Microangiopathy in Patients with Precapillary Pulmonary Hypertension: Correlation with Cardiac Function and Patients’ Functional Capacity. Study Design and Rationale
por: Arvanitaki, Alexandra, et al.
Publicado: (2020)

Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients
por: Roumeliotou, Argyro, et al.
Publicado: (2022)

Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
por: Giannopoulou, Efstathia, et al.
Publicado: (2015)

ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study
por: Daoussis, Dimitrios, et al.
Publicado: (2018)

Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study
por: Katsifis, Gkikas, et al.
Publicado: (2022)

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial
por: Koutras, Angelos, et al.
Publicado: (2020)

Functional Inflammatory Genotypes in Ischemic Stroke: Could We Use Them to Predict Age of Onset and Long-Term Outcome?
por: Marousi, Stella, et al.
Publicado: (2011)

Musculoskeletal Manifestations of Sarcoidosis
por: Hasbani, Georges El, et al.
Publicado: (2022)

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
por: Bafaloukos, Dimitrios, et al.
Publicado: (2010)

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study
por: Koutras, Angelos, et al.
Publicado: (2015)

Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
por: Rozis, Meletios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_575dlcu0o2ppir7sesdc72va6l